ArticleInternational journal of clinical oncology2022

First-line pembrolizumab for patients with early relapsing urothelial carcinoma after perioperative chemotherapy: a retrospective analysis of bladder cancer and upper urinary tract cancer.

Nobutaka Nishimura et al.PubMed ↗Publisher ↗

No numbers read from the abstract.